About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Phoenix | 8,240 Studies Near You

Clinical TrialsPhoenix

Clinical Trials in Phoenix

Discover 8,240 clinical trials near Phoenix, Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1541-1560 of 8,240 trials

CompletedPresatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory TractThe primary objective of this study is to evaluate the effect of presatovir on respiratory syncytial virus (RSV) viral load in autologous or allogeneic hematopoietic cell…NCT02254408·Phoenix, Arizona and 67 others

Find Trials by Condition in Phoenix

Breast Cancerin Phoenix Lung Cancerin Phoenix Prostate Cancerin Phoenix Colorectal Cancerin Phoenix Melanomain Phoenix Leukemiain Phoenix Lymphomain Phoenix Pancreatic Cancerin Phoenix Ovarian Cancerin Phoenix Brain Cancerin Phoenix Diabetes

Data from ClinicalTrials.govTerms

CompletedNavigation From Community to Clinic to Promote CRC Screening in Underserved PopulationsThe purpose of this study is to test the effectiveness of a two-phase intervention using "community-to-clinic navigators" to guide individuals from an especially hard-to-reach…NCT01853774·Phoenix, Arizona

CompletedAlbumin Use in Burn PatientsThis is a study of why and how physicians use albumin during the first 72 hours after a burn injury.NCT00609414·Phoenix, Arizona and 11 others

CompletedClinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"The primary objective of this study is to assess the sensitivity for colorectal cancer (CRC) and specificity of the mt-sDNA 2.0 test.NCT04144738·Birmingham, Alabama and 194 others

UnknownDose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) FailureThe main purpose of this research study is to evaluate the safety and dosing of CG0070.NCT00109655·Phoenix, Arizona and 9 others

CompletedA Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of PregnancyThis is an open-label, single treatment study. All subjects will receive 12 months of oral contraceptive therapy with DR-102.NCT01178125·Montgomery, Alabama and 61 others

CompletedMRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular HypertensionThe objective of this clinical study is to evaluate the safety and efficacy of NCX 470 Ophthalmic Solution in lowering intraocular pressure (IOP) in subjecs with ocular…NCT04630808·Dothan, Alabama and 87 others

TerminatedSafety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With InfluenzaThis Phase 1/2 protocol is designed to collect safety, tolerability and pharmacokinetic data of two doses of Laninamivir Octanoate in children and adolescents.NCT02014649·Phoenix, Arizona and 27 others

CompletedEfficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis PatientsThe objectives of the study were to evaluate the efficacy, safety, and tolerability of valdecoxib 10 mg once daily (QD) or naproxen 500 mg twice daily (BID) versus placebo, and to…NCT00650455·Birmingham, Alabama and 54 others

CompletedLong Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With AsthmaThe purpose of this study is to evaluate the safety of levalbuterol as compared to racemic albuterol based on the frequencies of adverse events reporting during a 12-month period…NCT00064389·Birmington, Alabama and 95 others

CompletedAn Extension Study in Participants With Moderate to Severe Rheumatoid ArthritisThe purpose of this study is to investigate the long-term safety and any side effects of baricitinib in participants who have completed a previous baricitinib rheumatoid arthritis…NCT01885078·Glendale, Arizona and 407 others

CompletedChronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)This is a prospective, multicenter, randomized, double-blind, placebo-controlled, parallel-group 3-arm study to investigate 2 different doses of subcutaneous (SC) IgPro20 compared…NCT01545076·Birmingham, Alabama and 90 others

Active not recruitingSyncAV Post-Market TrialThe SyncAV Post-Market Trial is a prospective, randomized, multi-center trial performed to determine if cardiac resynchronization therapy (CRT) devices programmed with SyncAV ON…NCT04100148·Huntsville, Alabama and 103 others

CompletedA Clinical Trial of PRAX-114 in Participants With Major Depressive DisorderThis is a randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of PRAX-114 in participants with moderate to severe major depressive…NCT04832425·Phoenix, Arizona and 30 others

CompletedA Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)This study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to semaglutide taken once a week in people with type…NCT05259033·Birmingham, Alabama and 192 others

TerminatedStudy of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast CancerThe goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of magrolimab in combination with nab-paclitaxel or paclitaxel (cohort 1) or…NCT04958785·Phoenix, Arizona and 44 others

CompletedEffect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary BypassDuring a heart bypass procedure, a substance called "complement" is released by the body.NCT00048308·Birmingham, Alabama and 185 others

CompletedMen's Sexual Risk Behaviors: Alcohol, Sexual Aggression, and Emotional FactorsAlthough correct, consistent condom use can greatly reduce sexually transmitted infections and unplanned pregnancies, resistance of condom use is common among young adults.NCT03900650·Phoenix, Arizona

CompletedEfficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in participants with Non-dialysis-dependent Chronic Kidney Disease…NCT02680574·Birmingham, Alabama and 502 others

CompletedPersistence With Prolia® (Denosumab) in Postmenopausal Women With OsteoporosisThe objective of this study was to describe persistence with Prolia® 60 mg administered subcutaneously (SC) every 6 months (Q6M) at 12 and 24 months.NCT02732210·Birmingham, Alabama and 88 others

PreviousPage 78 of 412Next

in Phoenix

Heart Diseasein Phoenix